Pediatric Exclusivity Incentives Proposed In European Commission Draft Reg
This article was originally published in The Pink Sheet Daily
Executive Summary
The lack of information on pediatric use of drugs remains a problem in Europe, EC's Brunet tells DIA EuroMeeting in Prague. A draft proposal would create a new marketing authorization system and provide data exclusivity to incentivize pediatric studies in off-patent drugs.